Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Brain‑wave and pain‑signal monitoring during anesthesia for ERCP to map opioid and sedative effects

Official title: Pharmacodynamic Effects of Propofol and Alfentanil on EEG During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Run by China Medical University Hospital · NCT07211828 · Data updated 2026-11-12

This trial will test whether continuous brain‑wave (EEG/PSI) and heart‑rate variability (ANI) monitoring during targeted infusions of opioids and sedatives can show how those drugs interact in people having ERCP under general anesthesia.

More Sedation and Analgesia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (Miaoli)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedDecember 31, 2026
Study endsJune 16, 2028
Registry record updatedMarch 27, 2026
Trial IDNCT07211828 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for ERCP who require general anesthesia and do not meet exclusion criteria (for example ASA class <4 and not members of vulnerable groups) are the intended participants.

Probably not a fit

Patients who are ASA class 4 or higher, prisoners, those with significant cognitive or physical disabilities, or HIV carriers were excluded and would not be eligible to participate or benefit from the protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants undergoing ERCP under general anesthesia will receive target‑controlled infusions (TCI) of opioids and sedatives with protocols comparing higher and lower alfentanil dosing combined with propofol while continuous EEG (PSI and raw EEG) and Analgesia Nociception Index (ANI) are recorded. The study will analyze how different dosing regimens influence PSI, raw EEG patterns, and HRV‑derived ANI to characterize pharmacodynamic interactions between opioids and sedatives. Data will be collected throughout the anesthesia period and correlated with infusion targets and clinical events to identify signal changes linked to sedation depth and nociception. Results aim to clarify how combined drug dosing affects common monitoring indices and support safer intraoperative dosing strategies.

Why it matters

Potential benefit: If successful, findings could help clinicians tailor opioid and sedative dosing during procedures like ERCP to reduce the risk of under‑ or over‑sedation.

How similar studies have gone: PSI and ANI have been used together in prior anesthetic practice and research to guide sedation and analgesia, but applying simultaneous TCI infusion protocols with combined PSI/EEG and ANI recording to map drug interactions is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who under go ERCP who require general anesthesia

Exclusion Criteria:

* ASA\> or = 4 , vulnerable groups such as prisoners, patients with physical or mental disabilities and HIV carriers

Where it's running

  • Wei Gong Memorial Hospital
    Miaoli, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.